Exploratory study for the efficacy and safety of Yokukansankachimpihange on behavioral and psychological symptoms of dementia (BPSD) in patients with Alzheimer's disease (AD).
Not Applicable
- Conditions
- AD patients with BPSD
- Registration Number
- JPRN-UMIN000018369
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with neurological disease to affect the cognitive function except AD. 2) Patients who have local lesion which affected the cognitive function by CT or MRI. 3) Patients with serious diseases such as malignant tumors, or disorder which is not in stable condition. 4) Patient who has an allergy to Kampo medicine. 5) Patients considered inappropriate by the study investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in neuropsychiatric inventory (NPI) total score before and after Yokukansankachimpihange treatment
- Secondary Outcome Measures
Name Time Method Changes in neuropsychiatric inventory (NPI) subscale score before and after Yokukansankachimpihange treatment